4-6 December 2018

London, UK

Speakers

Expand/Collapse

Elad Katz
Lead Biologist
Dundee University

Rajendra Kumari
General Manager & CSO
Crown Bioscience

Ralph Gareus
Director Business Development Europe
The Jackson Laboratories

Cristina Bertinetti-Lapatki
Principal Scientist, Investigative Safety
Roche

Dik C. van Gent
Associate Professor
Erasmus MC

Elizabeth Hardaker
Head, Oncology In Vivo Pharmacology Group
AstraZeneca

Fabien Garcon
Scientist I
MedImmune

Gavin Bennett
Head of Preclinical Development
Bicycle Therapeutics

Giorgio Seano
Head of Tumor Microenvironment Lab
Institut Curie Research Center

Jayesh Majithiya
Senior Scientist
Crescendo Biologics

Jean Viallet
CEO
Inovotion

Markus Reschke
Investigator III, Lab Head Oncology Research/Drug Discovery Pharmacology
Novartis

Marleen Van Loenen
Director - Non-Clinical Development
Gadeta

Maryland Franklin
Vice President – Scientific Development
MI Bioresearch

Anita Seshire
Head of Laboratory Cellular Pharmacology & Translational Innovation Platform Oncology
Merck KgGA

Ayako Pedersen
Head of Translational Research
IO Biotech APS

Anne Vaslin Chessex
Associate Director, Pharmacology & Screening
Debiopharm

Niina Veitonmäki
Director In Vivo Immune-Oncology
Molecular Partners AG

Alison Mackinnon
Preclinical Research Consultant
Galecto Biotech